Ralf Bieker

2.0k total citations
30 papers, 1.6k citations indexed

About

Ralf Bieker is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Ralf Bieker has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Ralf Bieker's work include Acute Myeloid Leukemia Research (13 papers), Angiogenesis and VEGF in Cancer (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Ralf Bieker is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Angiogenesis and VEGF in Cancer (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Ralf Bieker collaborates with scholars based in Germany, United States and Latvia. Ralf Bieker's co-authors include Rolf M. Mesters, Wolfgang E. Berdel, Teresa Padró, Martin Steins, Torsten Keßler, Joachim Kienast, Sandra Ruíz, Thomas Büchner, Horst Bürger and Christoph Schliemann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Radiology.

In The Last Decade

Ralf Bieker

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Bieker Germany 20 920 727 465 289 250 30 1.6k
Matthias Kotzsch Germany 30 1.1k 1.2× 607 0.8× 486 1.0× 530 1.8× 286 1.1× 75 2.3k
Mark B. Meads United States 12 771 0.8× 441 0.6× 753 1.6× 307 1.1× 148 0.6× 36 1.6k
Asumi Yokota Japan 25 817 0.9× 539 0.7× 519 1.1× 273 0.9× 375 1.5× 61 1.8k
Helena Kempski United Kingdom 22 747 0.8× 820 1.1× 389 0.8× 344 1.2× 204 0.8× 42 2.0k
Ben Van Camp Belgium 28 1.2k 1.3× 1.3k 1.8× 1.2k 2.5× 351 1.2× 246 1.0× 53 2.4k
Alessandra Di Bacco United States 21 1.5k 1.7× 829 1.1× 660 1.4× 203 0.7× 187 0.7× 42 1.9k
Wolfgang Eisterer Austria 21 564 0.6× 425 0.6× 712 1.5× 109 0.4× 280 1.1× 95 1.7k
B. Douglas Smith United States 13 899 1.0× 834 1.1× 776 1.7× 214 0.7× 183 0.7× 23 1.6k
Ivana Zavrski Germany 23 938 1.0× 888 1.2× 899 1.9× 151 0.5× 159 0.6× 34 1.6k
Michael Hundemer Germany 27 954 1.0× 1.0k 1.4× 719 1.5× 122 0.4× 266 1.1× 87 1.9k

Countries citing papers authored by Ralf Bieker

Since Specialization
Citations

This map shows the geographic impact of Ralf Bieker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Bieker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Bieker more than expected).

Fields of papers citing papers by Ralf Bieker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Bieker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Bieker. The network helps show where Ralf Bieker may publish in the future.

Co-authorship network of co-authors of Ralf Bieker

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Bieker. A scholar is included among the top collaborators of Ralf Bieker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Bieker. Ralf Bieker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bieker, Ralf, Torsten Keßler, Christian Schwöppe, et al.. (2009). Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience. Blood. 113(20). 5019–5027. 118 indexed citations
2.
Mesters, Rolf M., Torsten Keßler, Christian Schwöppe, et al.. (2008). Generation of Fusion Proteins for Selective Occlusion of Tumor Vessels. Current Drug Discovery Technologies. 5(1). 1–8. 31 indexed citations
3.
Thoennissen, Nils H., Ralf Bieker, Christoph Schliemann, et al.. (2008). Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis. Annals of Oncology. 19(9). 1644–1649. 32 indexed citations
4.
Schliemann, Christoph, Ralf Bieker, Nils H. Thoennissen, et al.. (2007). Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia. 21(9). 1901–1906. 48 indexed citations
5.
Liersch, Rüediger, Christoph Schliemann, Ralf Bieker, et al.. (2007). Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia. Leukemia Research. 32(6). 954–961. 27 indexed citations
6.
Keßler, Torsten, Frauke Fehrmann, Ralf Bieker, Wolfgang E. Berdel, & Rolf M. Mesters. (2007). Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies. Current Drug Targets. 8(2). 257–268. 42 indexed citations
7.
Persigehl, Thors ten, Ralf Bieker, Lars Matuszewski, et al.. (2007). Antiangiogenic Tumor Treatment: Early Noninvasive Monitoring with USPIO-enhanced MR Imaging in Mice. Radiology. 244(2). 449–456. 49 indexed citations
8.
Kreuter, Michael, Ralf Bieker, Christoph Schliemann, et al.. (2006). Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia. 20(11). 1950–1954. 49 indexed citations
9.
Schliemann, Christoph, Ralf Bieker, Teresa Padró, et al.. (2006). Expression of Angiopoietins and Their Receptor Tie2 in the Bone Marrow of Patients with Acute Myeloid Leukemia.. Blood. 108(11). 1894–1894. 37 indexed citations
10.
Keßler, Torsten, Ralf Bieker, Teresa Padró, et al.. (2005). Inhibition of Tumor Growth by RGD Peptide–Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature. Clinical Cancer Research. 11(17). 6317–6324. 70 indexed citations
11.
Reinmuth, Niels, Rolf M. Mesters, Ralf Bieker, et al.. (2004). Signal transduction pathways as novel therapy targets in lung cancer. Lung Cancer. 45. S177–S186. 5 indexed citations
12.
Kreuter, Michael, Ralf Bieker, Stefan Bielack, et al.. (2004). Prognostic relevance of increased angiogenesis in osteosarcoma. Journal of Clinical Oncology. 22(14_suppl). 9022–9022. 21 indexed citations
13.
Bieker, Ralf, Teresa Padró, Julia Krämer, et al.. (2003). Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.. PubMed. 63(21). 7241–6. 56 indexed citations
14.
Steins, Martin, Ralf Bieker, Teresa Padró, et al.. (2003). Thalidomide for the Treatment of Acute Myeloid Leukemia. Leukemia & lymphoma. 44(9). 1489–1493. 17 indexed citations
15.
Bieker, Ralf, Torsten Keßler, Wolfgang E. Berdel, & Rolf M. Mesters. (2003). Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma. Oncology Reports. 10(6). 1915–7. 10 indexed citations
16.
Bieker, Ralf, Christian Lerchenmüller, Hubert Serve, et al.. (2003). Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia. Oncology Reports. 10(4). 915–20. 19 indexed citations
17.
Padró, Teresa, Ralf Bieker, Sandra Ruíz, et al.. (2002). Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia. 16(7). 1302–1310. 173 indexed citations
18.
19.
Mesters, Rolf M., Teresa Padró, Martin Steins, et al.. (2001). Angiogenese bei hämatologischen Neoplasien. Oncology Research and Treatment. 24(5). 75–80. 8 indexed citations
20.
Padró, Teresa, Sandra Ruíz, Ralf Bieker, et al.. (2000). Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 95(8). 2637–2644. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Kotzsch Breakdown of academic impact, for papers by Mark B. Meads Breakdown of academic impact, for papers by Asumi Yokota Breakdown of academic impact, for papers by Helena Kempski Breakdown of academic impact, for papers by Ben Van Camp Breakdown of academic impact, for papers by Alessandra Di Bacco Breakdown of academic impact, for papers by Wolfgang Eisterer Breakdown of academic impact, for papers by B. Douglas Smith Breakdown of academic impact, for papers by Ivana Zavrski Breakdown of academic impact, for papers by Michael Hundemer
Rankless by CCL
2026